Published in J Neurotrauma on December 01, 2002
Structural neuroplasticity following T5 spinal cord transection: increased cardiac sympathetic innervation density and SPN arborization. Am J Physiol Regul Integr Comp Physiol (2010) 1.47
Genetic manipulation of intraspinal plasticity after spinal cord injury alters the severity of autonomic dysreflexia. J Neurosci (2006) 1.30
Segmental organization of spinal reflexes mediating autonomic dysreflexia after spinal cord injury. Prog Brain Res (2006) 1.19
Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury. Neurotherapeutics (2011) 1.16
Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J Neuroinflammation (2010) 1.15
Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection. J Comp Neurol (2008) 1.11
Central circuits regulating the sympathetic outflow to lumbar muscles in spinally transected mice by retrograde transsynaptic transport. Int J Clin Exp Pathol (2014) 0.97
The dark side of neuroplasticity. Exp Neurol (2011) 0.93
Partial restoration of cardiovascular function by embryonic neural stem cell grafts after complete spinal cord transection. J Neurosci (2013) 0.93
Cardiovascular and temperature changes in spinal cord injured rats at rest and during autonomic dysreflexia. J Physiol (2006) 0.92
Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injury. Front Physiol (2012) 0.90
Cardiovascular dysfunction following spinal cord injury. Neural Regen Res (2016) 0.88
Spinal cord injury: From inflammation to glial scar. Surg Neurol Int (2011) 0.82
Mechanisms inducing autonomic dysreflexia during urinary bladder distention in rats with spinal cord injury. Spinal Cord (2014) 0.82
The Transcriptional Response of Neurotrophins and Their Tyrosine Kinase Receptors in Lumbar Sensorimotor Circuits to Spinal Cord Contusion is Affected by Injury Severity and Survival Time. Front Physiol (2013) 0.78
The Adaptor Protein CD2AP Is a Coordinator of Neurotrophin Signaling-Mediated Axon Arbor Plasticity. J Neurosci (2016) 0.75
Transcriptional changes in sensory ganglia associated with primary afferent axon collateral sprouting in spared dermatome model. Genom Data (2015) 0.75
The cellular inflammatory response in human spinal cords after injury. Brain (2006) 3.01
Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J Neurosci (2004) 1.80
A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma (2010) 1.54
A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13
Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem (2004) 1.11
Chronic pain after clip-compression injury of the rat spinal cord. Exp Neurol (2002) 1.10
Neurotrophin-dependent tyrosine phosphorylation of Ras guanine-releasing factor 1 and associated neurite outgrowth is dependent on the HIKE domain of TrkA. J Biol Chem (2004) 1.10
A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma (2010) 1.10
The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain (2004) 1.08
The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp Neurol (2008) 1.04
Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats. Brain Res (2008) 1.02
Nerve growth factor activation of the TrkA receptor induces cell death, by macropinocytosis, in medulloblastoma Daoy cells. J Neurochem (2009) 1.01
Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J Neurosci (2005) 1.00
Human tumorous imaginal disc 1 (TID1) associates with Trk receptor tyrosine kinases and regulates neurite outgrowth in nnr5-TrkA cells. J Biol Chem (2005) 1.00
NGF message and protein distribution in the injured rat spinal cord. Exp Neurol (2004) 0.97
ShcB and ShcC activation by the Trk family of receptor tyrosine kinases. J Biol Chem (2002) 0.95
Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats. J Neurochem (2005) 0.95
Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function. Exp Neurol (2008) 0.95
Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury. Exp Neurol (2008) 0.94
Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J Neurotrauma (2005) 0.94
The dark side of neuroplasticity. Exp Neurol (2011) 0.93
Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J Neurosci Res (2007) 0.93
An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem (2004) 0.93
A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats. J Neurotrauma (2012) 0.92
An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury. Exp Neurol (2008) 0.91
Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion. J Neuroinflammation (2013) 0.91
Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J Neuropathol Exp Neurol (2012) 0.90
Trypanosome trans-sialidase mediates neuroprotection against oxidative stress, serum/glucose deprivation, and hypoxia-induced neurite retraction in Trk-expressing PC12 cells. Glycobiology (2007) 0.90
Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy. J Neurosurg Spine (2009) 0.90
NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat. Exp Neurol (2007) 0.89
Debate: "is increasing neuroinflammation beneficial for neural repair?". J Neuroimmune Pharmacol (2006) 0.89
Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells. J Biol Chem (2013) 0.88
CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury. Exp Neurol (2011) 0.88
Nesca, a novel adapter, translocates to the nuclear envelope and regulates neurotrophin-induced neurite outgrowth. J Cell Biol (2004) 0.86
A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury. J Neurotrauma (2011) 0.86
The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins. Endocrinology (2003) 0.85
The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade. J Neurotrauma (2012) 0.85
Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury. J Neurosci Res (2009) 0.85
Central mechanisms for autonomic dysreflexia after spinal cord injury. Prog Brain Res (2002) 0.85
Autonomic dysreflexia, induced by noxious or innocuous stimulation, does not depend on changes in dorsal horn substance p. J Neurotrauma (2004) 0.85
What causes autonomic dysreflexia after spinal cord injury? Clin Auton Res (2002) 0.85
Trk receptor binding and neurotrophin/fibroblast growth factor (FGF)-dependent activation of the FGF receptor substrate (FRS)-3. Biochim Biophys Acta (2006) 0.84
A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury. J Neurosurg Spine (2006) 0.84
Cellular imaging of inflammation after experimental spinal cord injury. Mol Imaging (2005) 0.84
Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model. J Neuroimmunol (2013) 0.83
Human spinal cord injury causes specific increases in surface expression of β integrins on leukocytes. J Neurotrauma (2011) 0.82
Effects of spinal cord injury on synaptic inputs to sympathetic preganglionic neurons. Prog Brain Res (2006) 0.82
Comparison of effects of methylprednisolone and anti-CD11d antibody treatments on autonomic dysreflexia after spinal cord injury. Exp Neurol (2005) 0.81
Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes. Inflamm Res (2010) 0.80
Nerve growth factor increases connexin43 phosphorylation and gap junctional intercellular communication. J Neurosci Res (2005) 0.80
The N-methyl-D-aspartate receptor splice variant NR1-4 C-terminal domain. Deletion analysis and role in subcellular distribution. J Biol Chem (2001) 0.79
The fibroblast growth factor receptor substrate 3 adapter is a developmentally regulated microtubule-associated protein expressed in migrating and differentiated neurons. J Neurochem (2009) 0.79
Genomic organization and comparative sequence analysis of the mouse and human FRS2, FRS3 genes. Mol Biol Rep (2003) 0.79
Magnetic resonance imaging versus histological assessment for estimation of lesion volume after experimental spinal cord injury. Laboratory investigation. J Neurosurg Spine (2008) 0.78
Effects of a novel tripeptide on neurological outcomes after spinal cord injury. Neuroreport (2006) 0.78
Nesca, a novel neuronal adapter protein, links the molecular motor kinesin with the pre-synaptic membrane protein, syntaxin-1, in hippocampal neurons. J Neurochem (2012) 0.78
Trypanosome trans-sialidase targets TrkA tyrosine kinase receptor and induces receptor internalization and activation. Glycobiology (2004) 0.77
Ras guanine nucleotide releasing factor 1 (RasGrf1) enhancement of Trk receptor-mediated neurite outgrowth requires activation of both H-Ras and Rac. J Mol Neurosci (2012) 0.77
The signaling adapter, FRS2, facilitates neuronal branching in primary cortical neurons via both Grb2- and Shp2-dependent mechanisms. J Mol Neurosci (2014) 0.77
Overexpression of the signaling adapter FRS2 reconstitutes the cell cycle deficit of a nerve growth factor non-responsive TrkA receptor mutant. J Neurochem (2002) 0.77
PC12nnr5 cells expressing TrkA receptors undergo morphological but not cholinergic phenotypic differentiation in response to nerve growth factor. J Neurochem (2002) 0.75
Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection. Exp Neurol (2003) 0.75
Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine. NMR Biomed (2015) 0.75